DK0751132T3 - Pyridazinonderivater og fremgangsmåder til fremstilling af samme - Google Patents

Pyridazinonderivater og fremgangsmåder til fremstilling af samme

Info

Publication number
DK0751132T3
DK0751132T3 DK96110412T DK96110412T DK0751132T3 DK 0751132 T3 DK0751132 T3 DK 0751132T3 DK 96110412 T DK96110412 T DK 96110412T DK 96110412 T DK96110412 T DK 96110412T DK 0751132 T3 DK0751132 T3 DK 0751132T3
Authority
DK
Denmark
Prior art keywords
preparing
processes
same
pyridazinone derivatives
pyridazinone
Prior art date
Application number
DK96110412T
Other languages
Danish (da)
English (en)
Inventor
Michihisa Yato
Shinsuke Nishiyama
Akihiko Ishida
Harutami Yamada
Fumikazu Okumura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of DK0751132T3 publication Critical patent/DK0751132T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Couplings Of Light Guides (AREA)
DK96110412T 1995-06-27 1996-06-27 Pyridazinonderivater og fremgangsmåder til fremstilling af samme DK0751132T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16062095 1995-06-27
JP1985996 1996-02-06

Publications (1)

Publication Number Publication Date
DK0751132T3 true DK0751132T3 (da) 2000-11-13

Family

ID=26356726

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96110412T DK0751132T3 (da) 1995-06-27 1996-06-27 Pyridazinonderivater og fremgangsmåder til fremstilling af samme

Country Status (21)

Country Link
US (2) US5698554A (de)
EP (1) EP0751132B1 (de)
KR (1) KR970061873A (de)
CN (1) CN1144802A (de)
AR (1) AR002602A1 (de)
AT (1) ATE195937T1 (de)
AU (1) AU694955B2 (de)
BG (1) BG62768B1 (de)
CA (1) CA2179939A1 (de)
DE (1) DE69610036T2 (de)
DK (1) DK0751132T3 (de)
ES (1) ES2151110T3 (de)
GR (1) GR3034910T3 (de)
HU (1) HUP9601766A3 (de)
IL (1) IL118631A (de)
MY (1) MY132263A (de)
NO (1) NO311084B1 (de)
PT (1) PT751132E (de)
RU (1) RU2131419C1 (de)
SG (1) SG46741A1 (de)
TW (1) TW432052B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2424551A1 (en) * 1997-05-27 1998-11-27 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
CO5200835A1 (es) * 1999-09-28 2002-09-27 Bayer Corp Piridinas y piridacinas sustituidas con actividad de inhibicion de angiogenesis
KR20030061051A (ko) * 2002-01-07 2003-07-18 대한민국 (경상대학교 총장) 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도
AR050552A1 (es) * 2004-09-02 2006-11-01 Osi Pharm Inc Mercaptoamidas como inhibidores de histona desacetilasa
CN101443317B (zh) * 2006-03-17 2011-07-06 住友化学株式会社 哒嗪酮化合物及其作为除草剂的用途
MX2009000884A (es) * 2006-07-25 2009-06-05 Cephalon Inc Derivados de piridizinona.
WO2009063244A1 (en) * 2007-11-15 2009-05-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Pyridazinone derivatives as parp inhibitors
EP2547203A4 (de) * 2010-03-19 2013-12-25 Purdue Research Foundation Ccr5-modulatoren zur hiv-behandlung
PH12013500907A1 (en) 2010-11-05 2013-07-08 Firmenich Incorporated Compounds useful as modulators of trpm8
MY157429A (en) 2011-06-24 2016-06-15 Amgen Inc Trpm8 antagonists and their use in treatments
JP2014517074A (ja) 2011-06-24 2014-07-17 アムジエン・インコーポレーテツド Trpm8アンタゴニストおよび治療におけるそれらの使用
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
EP3356356B1 (de) 2015-10-01 2021-05-26 Firmenich Incorporated Verbindungen als trpm8-modulatoren
ES2793239T3 (es) 2016-04-15 2020-11-13 Abbvie Inc Inhibidores del bromodominio
AU2019372121A1 (en) * 2018-10-30 2021-05-27 Nuvation Bio Inc. Heterocyclic compounds as BET inhibitors
AU2019374812B2 (en) 2018-11-06 2025-03-06 Edgewise Therapeutics, Inc. Pyridazinone compounds and uses thereof
KR102885525B1 (ko) 2018-11-06 2025-11-13 엣지와이즈 테라퓨틱스, 인크. 피리다지논 화합물 및 이의 용도
BR112021008905A2 (pt) 2018-11-06 2021-08-10 Edgewise Therapeutics, Inc. compostos de piridazinona e usos dos mesmos
AU2020299592A1 (en) 2019-07-02 2022-02-17 Nuvation Bio Inc. Heterocyclic compounds as BET inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6053022B2 (ja) 1977-04-07 1985-11-22 ウェルファイド株式会社 ピリダジノン誘導体
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
JPS6193169A (ja) * 1984-10-12 1986-05-12 Sankyo Co Ltd ピリダジノン誘導体及びその製法
KR860007219A (ko) * 1985-03-12 1986-10-08 베쩰, 좀머 설포닐아미노에틸 화합물의 제조방법
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3508692A1 (de) 1985-03-12 1986-09-18 Dr. Karl Thomae Gmbh, 7950 Biberach 3-(4-(2-benzolsulfonylamino-aethyl)-benzoyl)propionsaeure, diese verbindung enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JPS63145272A (ja) * 1986-12-09 1988-06-17 Morishita Seiyaku Kk 4,5−ジヒドロ−6−(4−置換フエニル)−3(2h)−ピリダジノン誘導体
SU1486061A3 (ru) * 1987-03-26 1989-06-07 Mitsubishi Chem Ind Способ получения производных пиридазинона или их солей
DE3728491A1 (de) * 1987-08-26 1989-03-09 Heumann Pharma Gmbh & Co Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
WO1992015558A1 (fr) 1991-03-01 1992-09-17 Zeria Pharmaceutical Co., Ltd. Derive d'indane et antagoniste de thromboxane le contenant
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
JP2616584B2 (ja) * 1992-07-02 1997-06-04 田辺製薬株式会社 ピリダジノン誘導体及びその製法
JP2757353B2 (ja) * 1993-12-28 1998-05-25 田辺製薬株式会社 インダン誘導体、その製法及びその合成中間体
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same

Also Published As

Publication number Publication date
EP0751132B1 (de) 2000-08-30
ATE195937T1 (de) 2000-09-15
HUP9601766A2 (en) 1997-02-28
DE69610036T2 (de) 2001-04-12
NO311084B1 (no) 2001-10-08
US5808065A (en) 1998-09-15
MY132263A (en) 2007-09-28
DE69610036D1 (de) 2000-10-05
HUP9601766A3 (en) 1998-04-28
GR3034910T3 (en) 2001-02-28
SG46741A1 (en) 1998-02-20
HU9601766D0 (en) 1996-08-28
BG62768B1 (bg) 2000-07-31
RU2131419C1 (ru) 1999-06-10
NO962643D0 (no) 1996-06-21
IL118631A0 (en) 1996-10-16
TW432052B (en) 2001-05-01
BG100684A (bg) 1997-03-31
NO962643L (no) 1996-12-30
AR002602A1 (es) 1998-03-25
PT751132E (pt) 2000-12-29
US5698554A (en) 1997-12-16
AU694955B2 (en) 1998-08-06
CA2179939A1 (en) 1996-12-28
AU5622196A (en) 1997-01-09
EP0751132A1 (de) 1997-01-02
KR970061873A (ko) 1997-09-12
ES2151110T3 (es) 2000-12-16
IL118631A (en) 2002-05-23
CN1144802A (zh) 1997-03-12

Similar Documents

Publication Publication Date Title
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
BR9703332A (pt) Derivados de piridazinona
DK1036794T3 (da) 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf
DK80593D0 (da) Fremgangsmaade og anlaeg til udvejning af genstandsportioner
NO973879L (no) Stent, og fremgangsmÕte for fremstilling av samme
NO985329D0 (no) FremgangsmÕte for Õ fremstille koplymerer og blandinger inneholdende det samme
DK0936873T3 (da) Coatet konfektureprodukter og fremgangsmåder til fremstilling af samme
DK1015444T3 (da) Pyrimidinderivater og fremgangsmåder til fremstilling deraf
DK0677321T3 (da) Slangeenhed og fremgangsmåde til fremstilling af samme.
DK0676438T3 (da) Orienteret film, der er let at spalte, og fremgangsmåde til fremstilling af den
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO950174D0 (no) PLL syntetiserer og fremgangsmåte for styring av samme
GR3034910T3 (en) Pyridazinone derivatives and processes for preparing the same
DK0909270T3 (da) Fremgangsmåde til fremstilling af 2,4-dihydroxypyridin og 2,4-dihydroxy-3-nitropyridin
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0974268T3 (da) Bifidobakterie-fermenteret mælk og fremgangsmåde til produktion af samme
DK0625586T3 (da) Konstruktionselement og fremgangsmåde til fremstilling af dette
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
FI956300A7 (fi) Pyridatsinonijohdannaisia
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK1020524T3 (da) Mutant bioluminescerende protein og fremgangsmåde til fremstilling af det mutante bioluminescerende protein
NO941997D0 (no) Fremgangsmåte for belegging av fröplante og system for fremgangsmåtens utförelse
NO974058D0 (no) Fargestoff og framgangsmåte for framstilling av samme
DK1524268T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer